IFITM3 and viral infectious disease: Given the current lack of strong evidence supporting the expression of Δ(1–21) IFITM3 in the rs12252 CC carriers [47,48], the molecular mechanisms behind the association of rs12252 CC with viral infections warrant further investigation.